Iron Deficient clinical trials

Explore recruiting iron deficient clinical trials.

Recruiting iron deficient studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Iron Deficient trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Tittle: Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer. A double blinded clinical randomized trial.

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of intravenous ferric carboxymaltose on mortality and cardiovascular morbidity, and quality of life in iron deficient patients with recent myocardial infarction

Poland

Therapeutic use (Phase IV) EU CTIS Study details

A phase III, randomized, open-label, blinded endpoint, comparative trial of ferric derisomaltose versus no intravenous iron in iron-deficient subjects with symptomatic chronic heart failure

Poland, Lithuania, Croatia, Hungary, Slovakia, Latvia +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomised, double-blind, three parallel-group, placebo controlled superiority trial assessing the effect of intravenous versus oral iron supplementation on physical performance, quality of life and cognitive function in iron deficient FRAIL elderly IndiviDuals with cardiovascular disease (FRAIL-ID trial)

Poland

Therapeutic use (Phase IV) EU CTIS Study details

Iron Deficient trials by city

Iron Deficient in Toronto Iron Deficient in Vancouver Iron Deficient in Montreal Iron Deficient in Calgary Iron Deficient in Edmonton Iron Deficient in Ottawa Iron Deficient in Winnipeg Iron Deficient in Quebec City Iron Deficient in Hamilton Iron Deficient in Kitchener Iron Deficient in London Iron Deficient in Halifax Iron Deficient in New York Iron Deficient in Los Angeles Iron Deficient in Chicago Iron Deficient in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease